| Product Code: ETC7646958 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Israel continued to rely on imports of budesonide inhalers, with top exporting countries being Switzerland, UK, Belgium, USA, and Germany. The low Herfindahl-Hirschman Index (HHI) indicates a competitive market landscape. However, the compound annual growth rate (CAGR) for 2020-2024 was negative at -2.14%, with a slight decline in growth rate from 2023 to 2024 at -0.41%. This data suggests a stable but challenging market environment for budesonide inhaler imports in Israel.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Budesonide Inhaler Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Budesonide Inhaler Market Revenues & Volume, 2022 & 2032F |
3.3 Israel Budesonide Inhaler Market - Industry Life Cycle |
3.4 Israel Budesonide Inhaler Market - Porter's Five Forces |
3.5 Israel Budesonide Inhaler Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Israel Budesonide Inhaler Market Revenues & Volume Share, By Dosage, 2022 & 2032F |
3.7 Israel Budesonide Inhaler Market Revenues & Volume Share, By Strength, 2022 & 2032F |
3.8 Israel Budesonide Inhaler Market Revenues & Volume Share, By End-Users, 2022 & 2032F |
3.9 Israel Budesonide Inhaler Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
4 Israel Budesonide Inhaler Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of respiratory disorders in Israel |
4.2.2 Growing awareness about the benefits of using budesonide inhalers for asthma and COPD management |
4.2.3 Technological advancements in inhaler devices leading to improved drug delivery |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval and market entry |
4.3.2 Competition from alternative treatment options such as oral medications |
4.3.3 Potential side effects associated with long-term use of budesonide inhalers |
5 Israel Budesonide Inhaler Market Trends |
6 Israel Budesonide Inhaler Market, By Types |
6.1 Israel Budesonide Inhaler Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Budesonide Inhaler Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 Israel Budesonide Inhaler Market Revenues & Volume, By Nebulizer, 2022 - 2032F |
6.1.4 Israel Budesonide Inhaler Market Revenues & Volume, By Inhalants, 2022 - 2032F |
6.2 Israel Budesonide Inhaler Market, By Dosage |
6.2.1 Overview and Analysis |
6.2.2 Israel Budesonide Inhaler Market Revenues & Volume, By Dry Powder, 2022 - 2032F |
6.2.3 Israel Budesonide Inhaler Market Revenues & Volume, By Spray, 2022 - 2032F |
6.2.4 Israel Budesonide Inhaler Market Revenues & Volume, By Suspension, 2022 - 2032F |
6.2.5 Israel Budesonide Inhaler Market Revenues & Volume, By Aerosols, 2022 - 2032F |
6.3 Israel Budesonide Inhaler Market, By Strength |
6.3.1 Overview and Analysis |
6.3.2 Israel Budesonide Inhaler Market Revenues & Volume, By 0.25mg, 2022 - 2032F |
6.3.3 Israel Budesonide Inhaler Market Revenues & Volume, By 0.5mg, 2022 - 2032F |
6.3.4 Israel Budesonide Inhaler Market Revenues & Volume, By 1.0mg, 2022 - 2032F |
6.4 Israel Budesonide Inhaler Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Israel Budesonide Inhaler Market Revenues & Volume, By Clinic, 2022 - 2032F |
6.4.3 Israel Budesonide Inhaler Market Revenues & Volume, By Hospital, 2022 - 2032F |
6.5 Israel Budesonide Inhaler Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Israel Budesonide Inhaler Market Revenues & Volume, By Hospital Pharmacy, 2022 - 2032F |
6.5.3 Israel Budesonide Inhaler Market Revenues & Volume, By Retail Pharmacy, 2022 - 2032F |
6.5.4 Israel Budesonide Inhaler Market Revenues & Volume, By Online Pharmacy, 2022 - 2032F |
7 Israel Budesonide Inhaler Market Import-Export Trade Statistics |
7.1 Israel Budesonide Inhaler Market Export to Major Countries |
7.2 Israel Budesonide Inhaler Market Imports from Major Countries |
8 Israel Budesonide Inhaler Market Key Performance Indicators |
8.1 Patient adherence rate to budesonide inhaler therapy |
8.2 Number of healthcare providers prescribing budesonide inhalers |
8.3 Rate of hospitalizations for respiratory exacerbations among patients using budesonide inhalers |
9 Israel Budesonide Inhaler Market - Opportunity Assessment |
9.1 Israel Budesonide Inhaler Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Israel Budesonide Inhaler Market Opportunity Assessment, By Dosage, 2022 & 2032F |
9.3 Israel Budesonide Inhaler Market Opportunity Assessment, By Strength, 2022 & 2032F |
9.4 Israel Budesonide Inhaler Market Opportunity Assessment, By End-Users, 2022 & 2032F |
9.5 Israel Budesonide Inhaler Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
10 Israel Budesonide Inhaler Market - Competitive Landscape |
10.1 Israel Budesonide Inhaler Market Revenue Share, By Companies, 2025 |
10.2 Israel Budesonide Inhaler Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here